- Research works
- 85 ▼ 6% vs 2013–17
- Citations
- 593 7.0 per fractional work
- Top-10% rate
- 4.6% record average 16.5%
- Open access
- 54% world 28%
Not ranked overall: Alkem (India) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 15.0×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 15.0×
- Immunology and Microbiology 3.2×
- Medicine 3.1×
- Chemistry 3.0×
- Biochemistry, Genetics and Molecular Biology 2.6×
- Business, Management and Accounting 1.2×
- Neuroscience 1.1×
- Economics, Econometrics and Finance 1.0×
- Health Professions 0.7×
- Decision Sciences 0.5×
- Materials Science 0.3×
- Environmental Science 0.2×
- Computer Science 0.1×
- Agricultural and Biological Sciences 0.1×
- Engineering 0.0×
Who are the top researchers at Alkem (India)?
Ranked on the composite score, Abhijit Trailokya lead among researchers whose main affiliation is Alkem (India).
- 1 Abhijit Trailokya India · #1,618,345 worldwide 5 citations · 16 works
Which keywords describe research at Alkem (India)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Cardiovascular Disease, Epidemiology, Diagnosis, Treatment, Diabetes, Inflammation, Antimicrobial Resistance and Heart Failure.
- Supply Chain Management
- Estrogen
- Autoantibodies
- Obesity
- Global Prevalence
- Risk Factors
- B-Type Natriuretic Peptide
- Immune Response
- Quality of Life
- Insulin Resistance
- Deficiency
- Continuous Infusion
- Antibiotic Pharmacokinetics
- Insulin Therapy
- Guidelines
- Heart Failure
- Cancer
- Diabetes
- Diagnosis
- Cardiovascular Disease
- Epidemiology
- Inflammation
- Treatment
- Antimicrobial Resistance
- Glycemic Control
- Antibiotic Resistance
- ESKAPE Pathogens
- Multidrug-Resistant Bacteria
- Clinical Practice Guideline
- Critically Ill Patients
- Genetics
- Metabolic Syndrome
- Vitamin D
- Asthma
- Hospital Readmission
- Breast Cancer
- Glucose Metabolism
- Type 1 Diabetes
- Blood Donation
- Receptor
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology5▲ 4.0×14 topics
- Cardiovascular Disease4▲ 12×5 topics
- Inflammation3▲ 4.4×12 topics
- Diagnosis3▲ 9.4×8 topics
- Treatment3▲ 6.9×6 topics
- Diabetes2▲ 15×3 topics
- Antimicrobial Resistance2▲ 34×3 topics
- Cancer2▲ 5.0×4 topics
- Glycemic Control2▲ 41×3 topics
- Heart Failure2▲ 15×4 topics
- Antibiotic Resistance2▲ 16×3 topics
- Guidelines2▲ 11×2 topics
- ESKAPE Pathogens2▲ 74×1 topic
- Insulin Therapy2▲ 36×2 topics
- Multidrug-Resistant Bacteria2▲ 74×1 topic
- Antibiotic Pharmacokinetics1▲ 141×1 topic
- Clinical Practice Guideline1▲ 88×2 topics
- Continuous Infusion1▲ 118×2 topics
- Critically Ill Patients1▲ 141×1 topic
- Deficiency1▲ 109×1 topic
- Genetics1▲ 5.9×4 topics
- Insulin Resistance1▲ 9.1×2 topics
- Metabolic Syndrome1▲ 5.1×2 topics
- Quality of Life1▲ 2.9×4 topics
- Vitamin D1▲ 127×1 topic
- Immune Response1▲ 7.0×4 topics
- Asthma1▲ 36×2 topics
- B-Type Natriuretic Peptide1▲ 71×1 topic
- Hospital Readmission1▲ 71×1 topic
- Risk Factors1▲ 3.3×3 topics
- Breast Cancer1▲ 14×2 topics
- Global Prevalence1▲ 36×2 topics
- Glucose Metabolism1▲ 33×1 topic
- Obesity1▲ 4.2×1 topic
- Type 1 Diabetes1▲ 37×2 topics
- Autoantibodies1▲ 13×5 topics
- Blood Donation1▲ 180×1 topic
- Estrogen1▲ 79×1 topic
- Receptor1▲ 93×1 topic
- Supply Chain Management1▲ 3.2×1 topic
Which research topics does Alkem (India) publish most on?
By volume in 2022–2025: Antibiotic Resistance in Bacteria, Antibiotics Pharmacokinetics and Efficacy, Vitamin D Research Studies and Heart Failure Treatment and Management.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Antibiotic Resistance in Bacteria Molecular Medicine 2 works
- 2 Antibiotics Pharmacokinetics and Efficacy Pharmacology 1 works
- 3 Vitamin D Research Studies Pathology and Forensic Medicine 1 works
- 4 Heart Failure Treatment and Management Cardiology and Cardiovascular Medicine 1 works
- 5 Diabetes, Cardiovascular Risks, and Lipoproteins Endocrinology, Diabetes and Metabolism 1 works
- 6 Blood donation and transfusion practices Management of Technology and Innovation 1 works
- 7 Estrogen and related hormone effects Genetics 1 works
- 8 Asthma and respiratory diseases Physiology 1 works
- 9 Inflammatory mediators and NSAID effects Pharmacology 1 works
- 10 Diabetes Management and Education Endocrinology, Diabetes and Metabolism 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Alkem (India)'s research output changed?
Output in 2018–2022 was 6% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Mumbai
- Indian Institute of Technology Bombay
- Bhabha Atomic Research Centre
- Tata Institute of Fundamental Research
- University of Mumbai
- Institute of Chemical Technology
- Homi Bhabha National Institute
- Tata Memorial Hospital
- Narsee Monjee Institute of Management Studies
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.